Literature DB >> 18813105

The utility of a specific measure for heart transplant patients: reliability and validity of the Kansas City Cardiomyopathy Questionnaire.

Teresa Ortega1, Beatriz Díaz-Molina, Ma Angeles Montoliu, Francisco Ortega, Covadonga Valdés, Pablo Rebollo, Maria Almenar, Marta Iscar.   

Abstract

BACKGROUND: Health-Related Quality of Life of patients with heart transplantation is an important variable; however, it has received little attention so far, and only two Spanish validated measurement instruments are available. The aim of our study was to validate the Spanish version of the Kansas City Cardiomyopathy Questionnaire (KCCQ) in heart transplant patients.
METHODS: A prospective study was performed in 186 patients awaiting heart transplantation in nine transplant hospitals. Hundred transplant recipients filled out the KCCQ, the Euroqol 5-D (EQ5D), and the Short Form-36 (SF-36) Health Survey at pretransplant, after 3 months, 6 months, and 1 year of follow-up. A complete set of sociodemographic and clinical data were also collected. The validity, reliability, sensitivity to change, and effect size were studied. Two questionnaires, the SF-36 and EQ5D, were used to evaluate the validity.
RESULTS: Mean age of patients was 56.0 years, and 80.5% were men. Twenty-six percent had acute rejection. A five-dimensional factorial structure could be discerned. The questionnaire presented a Cronbach's alpha coefficient of more than 0.7. Correlations between the KCCQ and the other questionnaires and clinical variables were satisfactory.
CONCLUSIONS: The KCCQ features adequate psychometric properties. The KCCQ offers several advantages over other questionnaires because it quantifies symptoms (frequency, severity, and stability) and it is much more sensitive to change, even when compared with the SF-36. The specific questionnaire for heart transplant patients is a useful and user-friendly instrument for measuring the Health-Related Quality of Life related to functional status, quality of life, and social limitation more accurately.

Entities:  

Mesh:

Year:  2008        PMID: 18813105     DOI: 10.1097/TP.0b013e318183eda4

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Patient selection for advanced heart failure therapy referral.

Authors:  Alexander C Fanaroff; Adam D DeVore; Robert J Mentz; Mani A Daneshmand; Chetan B Patel
Journal:  Crit Pathw Cardiol       Date:  2014-03

2.  Multinational and multiethnic variations in health-related quality of life in patients with chronic heart failure.

Authors:  Nancy Luo; Tiew-Hwa Katherine Teng; Wan Ting Tay; Inder S Anand; William E Kraus; Houng Bang Liew; Lieng Hsi Ling; Christopher M O'Connor; Ileana L Piña; A Mark Richards; Wataru Shimizu; David J Whellan; Jonathan Yap; Carolyn S P Lam; Robert J Mentz
Journal:  Am Heart J       Date:  2017-07-01       Impact factor: 4.749

3.  Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION.

Authors:  Nancy Luo; Christopher M O'Connor; Lauren B Cooper; Jie-Lena Sun; Adrian Coles; Shelby D Reed; David J Whellan; Ileana L Piña; William E Kraus; Robert J Mentz
Journal:  Eur J Heart Fail       Date:  2018-08-31       Impact factor: 15.534

4.  Patient-reported selective adherence to heart failure self-care recommendations: a prospective cohort study: the Atlanta Cardiomyopathy Consortium.

Authors:  Catherine N Marti; Vasiliki V Georgiopoulou; Grigorios Giamouzis; Robert T Cole; Anjan Deka; W H W Tang; Sandra B Dunbar; Andrew L Smith; Andreas P Kalogeropoulos; Javed Butler
Journal:  Congest Heart Fail       Date:  2012-09-09

5.  Psychometric properties of the Kansas City Cardiomyopathy Questionnaire (KCCQ).

Authors:  Ruth Masterson Creber; Rosemary Polomano; John Farrar; Barbara Riegel
Journal:  Eur J Cardiovasc Nurs       Date:  2012-03-28       Impact factor: 3.908

6.  Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure.

Authors:  Sri Lekha Tummalapalli; Leila R Zelnick; Amanda H Andersen; Robert H Christenson; Christopher R deFilippi; Rajat Deo; Alan S Go; Jiang He; Bonnie Ky; James P Lash; Stephen L Seliger; Elsayed Z Soliman; Michael G Shlipak; Nisha Bansal
Journal:  J Am Heart Assoc       Date:  2020-06-24       Impact factor: 5.501

7.  Predicting Self-Rated Health in Diabetes and Chronic Heart Failure - A Multiple Mediation Model.

Authors:  Sylvia Böhme; Babette Renneberg
Journal:  Front Public Health       Date:  2015-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.